ATP5F1A and Parkinson disease: For example, FV-derived fucoidan has been shown to alleviate mitochondrial dysfunction and prevent dopaminergic neuron loss in a Parkinson’s disease mouse model, effects mediated via the regulation of ATP5F1a, a key mitochondrial protein [47].